Daily news email for March 26, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
Definiens Expands Stereology Capabilities for Quantitative Digital Pathology

Ceva Takes Commercial License for ProBioGen's AGE1.CR Cell Line for Viral Vaccine Production

UCB and Domainex Collaboration Provides Valuable Information on Cancer Drug Target

Medicyte and PRIMACYT Receive Grant to Develop Human Liver Cells for Cell-based Therapies

Annual Report on Celera (Quest) License

Inner Weapons Against Allergies: Gut Bacteria Control Allergic Diseases, University of Pennsylvania Study

Brain Size May Determine Whether You are Good at Keeping Friends, University of Oxford Study

Who Knew Fruit Flies Get Kidney Stones Too, Mayo Clinic and University of Glasgow Study

Biomarkers for Autism Discovered, Uppsala Universitet Study

The Body's Bacteria Affect Intestinal Blood Vessel Formation, University of Gothenburg Study

BioSpace - Breaking News
Janssen Research & Development, LLC Release: XARELTO (rivaroxaban) Demonstrates Comparable Efficacy to Standard of Care for the Treatment and Secondary Prevention of Venous Blood Clots in Patients with Symptomatic Pulmonary Embolism in Pivotal Phase 3 Study

PLoS ONE Journal Publishes Mechanistic Model of Alzheimer's Disease Endorsing PRANA Biotechnology's PBT2

ARCA biopharma Release: GencaroTM's Norepinephrine Lowering Likely Contributes to its Effect in Atrial Fibrillation Prevention

Raptor Pharmaceutical Inc. Announces EMA Validation of Marketing Authorization Application for RP103 for the Treatment of Nephropathic Cystinosis

VIVUS, Inc. Announces Acceptance of Avanafil Application in Europe

Biotech News - Business Wire
Kips Bay Medical Announces Move to NASDAQ Capital Market

Chroma Certified a "Green Partner" by Sony

nSpire Health Reports Record Profits for 2011

Biomet Announces Resolution to FCPA Investigation

BioInvent International AB Annual General Meeting

Biotech News - PR Newswire
Health Courts Continue to Gain Bipartisan Support From 2012 Presidential Candidates

Tengion Reports Fourth Quarter and Full Year 2011 Financial Results

The 14th Annual L'Oréal-Unesco Awards or Women on Science: From March 26 to March 29, Paris Welcomes and Honours Tomorrow's Scientific Talents

Aviir Diagnostics Laboratory in Collaboration with Cause;ology Sponsors "Storyland," a Red Carpet Charity Extravaganza in Hollywood

Sanofi et Regeneron annoncent des résultats positifs de phase II pour un anticorps anti-PCSK9 à effet hypolipémiant

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
Roche and Illumina Duke It out Ahead of Annual Meeting

Groups Seek Congressional Action on Drug Shortages

JNJ Faces Flood of Lawsuits for Unauthorized Medical Device

MediVector Lands $138.5 Million Defense Contract

Unauthorized Distribution of Medical Device Leads to 550 Lawsuits

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
Satellite Healthcare Takes an Active Role in the Future of HealthcareLeads Quality Panel, Sponsors First National Summit on Home Dialysis Policy in Washington, D.C.

Medtronic-Sponsored Study Finds Pacemakers Reduce Fainting in Patients

Premier Healthcare Alliance Named the Healthiest Employer among Large Businesses in Charlotte

American College of Cardiology Poster Abstract Shows Standard Lipid Profile Inaccurate for LDL Cholesterol Below 70 mg/dL

Emerge Medical Inc. Added to Premier's General Orthopedic Trauma Agreement

Clinical Trials - PR Newswire
Essential Tremor Patient Regains Independence Following Surgery

Christiana Care Health System's Mark Garcia, M.D. Identifies Successful Treatments for Chronic Deep Vein Thrombosis

Benvenue Medical Announces U.S. Launch of the Blazer Vertebral Augmentation System

Interventional Radiologists Fight Post-Thrombotic Syndrome, Provide Hope for Chronic DVT

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

CNN Top Stories
Drunk driving charge for Bobby Brown

Pope arrives in Cuba after Mexico visit

Officials: Bales sneaked off base twice


Toobin: Huge stakes

Contract Pharma
Cetero Files For Bankruptcy

Impax, Tolmar in Development and Supply Pact

Pilgrim Appoints CFO

Elite Pharma in Development Pact

Biomar Expands API Capacity

FDA Drugs- What's New
Postmarketing Requirements and Commitments: Reports

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: Cambios importantes en la etiqueta de seguridad de los medicamentos para reducir el colesterol conocidos como estatinas

FDA Drug Safety Communication: Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury

FDA News - Business Wire
Teva Announces FDA Approval of QNASLTM (beclomethasone dipropionate), a New Nonaqueous Nasal Aerosol, for the Treatment of Allergic Rhinitis

US Court Denies Preliminary Injunction Application against the FDA and Dismisses AstraZeneca's Lawsuit without Prejudice

Medtronic Resolute® Drug-Eluting Stent Delivers Durable Clinical Outcomes Through Two Years in Major Studies

St. Jude Medical Announces Next-Generation PressureWire for FFR Measurement

Hyperion Therapeutics Acquires Ravicti (Glycerol Phenylbutyrate) From Ucyclyd Pharma, Inc.

FDA Press Releases
FDA approves LINX Reflux Management System to treat gastroesophageal reflux disease

FDA approves first Boniva generics to treat or prevent osteoporosis

FDA proposes lower risk classification, guidance for certain tuberculosis tests

FDA proposes lower risk classification for certain tuberculosis tests

FDA approves first generic Lexapro to treat depression and anxiety disorder

FDA Vaccines, Blood and Biologics - What's New
WinRho SDF Liquid

Flebogamma DIF 5%

Cord Blood Banking Information for Consumers

Cord Blood Banking – Information for Consumers

Cord Blood Banking ââ¬â Information for Consumers

Tesaro promises rapid progress with cancer drugs in $86M IPO

Sanofi, Regeneron report stellar LDL drug data as race heats up

Fierce's Top 10 Biotech techies

FDA accusations of 'corrupt' lab practices push Cetero into bankruptcy

Amgen CEO's retirement pay could register at $49M

FierceBiotech IT
Dr. Atul Butte - Fierce's Top 10 Biotech Techies

Samir Brahmachari - Fierce's Top 10 Biotech Techies

Seth Cooper - Fierce's Top 10 Biotech Techies

Dr. Atul Butte - Fierce's Top 10 Biotech Techies

Jeffrey Keisling - Fierce's Top 10 Biotech Techies

FierceBiotech Research
Stem cell research progress proliferating in 2012

Protein deficiency seen as tantalizing key to type 2 diabetes

Researchers coaxed immature brain stem cells from mouse connective tissue

U-M may face drop in state dollars over embryonic stem cell reporting battle

U-M may face drop in state $ over embryonic stem cell reporting battle

With patent running out, AZ loses bid to block Seroquel copies

Valeant nabs Russia's Natur Produkt for $175M-plus

AZ's Brennan nabs 11% pay hike to $5.89M

Roche to offer cancer drugs in India at deep discounts

Bare shelves in docs' sample closets as pharma overhauls sales

FiercePharma Manufacturing
Congress probes whether small wholesalers are gouging drug prices

Nobilus Poland plant gets import ban after FDA warning

Distribution, supply chain key to Eli Lilly's China expansion

Explosion, fire at Teva's Pliva plant turns deadly

GSK to invest more than £500 million in new manufacturing in U.K.

ImmunoCellular licenses new ovarian cancer target

UPDATED: GSK investing in U.K. vaccine manufacturing

iBio shares jump with flu shot clinical trial

TB vaccine in South African trials; blueprint will drive development

GSK investing in U.K. vaccine manufacturing

Health News - BizJournals.com
Memphis in spotlight for NBA's Hoops for St. Jude Night

U.S. Supreme Court hears health care reform law challenge

Tengion says progress made on key research goals

Mullins resigns as Alabama Medicaid commissioner

Insurance, commodities cut SRI Surgical's bottom line

Health News - CNBC
Obama campaign: Obamacare not a bad word after all

Regeneron and Sanofi say drug reduced cholesterol

Dueling chants as demonstrators vent over U.S. healthcare law

Device maker Biomet paying $22.7M in US accords

Diabetes Breakthrough

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
Celtic Pledges $50M to Establish Business to Develop Antibody-Drug Conjugates

Enterome Raises 5M to Develop Gut Bacteria-Based Disease and Drug-Response Biomarkers

Enterome Raises 5M to Develop Gut Bacteria-Based Disease and Drug Response Biomarkers

GSK Confirms £500M Investment in Manufacturing Across Multiple U.K. Sites

Watson Rumored to Be Talking to Actavis About a 5B Acquisition Deal

Marketwire - Pharma and Biotech
Response Biomedical Corporation Schedules Fourth Quarter and Fiscal Year 2011 Earnings Release and Announces Conference Call

ProMetic Reports Its Year End 2011 Highlights and Financial Results

ProMetic annonce ses faits saillants et rltats financiers de l'exercice 2011

Bausch + Lomb to Acquire ISTA Pharmaceuticals

ISTA Pharmaceuticals Announces Settlement on Royalty Dispute

MassBio News
Norton High School Named MassBioEd Innovative School of the Year

Vertex Founder Joshua Boger to Receive MassBio's Henri Termeer Innovative Leadership Award

MassBio Launches New Blog: MassBioHQ

What has made Massachusetts a better place for biotech Make your nomination by 5 PM on Feb. 24th!

What has made Massachusetts a better place for biotech Make your nomination by Feb. 24th!

Medical Pharma - PR Newswire
Obesity Medicine Physicians Offer Sustainable Weight Loss Tips to Type 2 Diabetic Patients

VICTRELIS Now Available for Eligible Patients in British Columbia

Global Healthy Living Foundation Launches "What's Your Affordable Care (F)act" YouTube Campaign

PharmaForm announces commercial manufacturing contract for Corcept's Korlym

Spotlight on China: Navigating the Barriers

National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

Nature Biotechnology
Know before you go

Confronting the Gordian knot

Agbiotech 2.0

Tiptoeing around transgenics

Mission Therapeutics

New York Times- Biotechnology
Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research

Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge

New York Times- Pharmaceuticals
Drug to Cut Cholesterol Level Tests Better Than Statins

The Case for Sleep Medicine

A Bizarre Outcome on Generic Drugs

Drug Giants Back New Venture Capital Fund

Drug Dosage Was Approved Despite Warning

1Q12 White Paper | A is for Innovation And

Promedior, Inc.: Series D $21.5M

Collegium Pharmaceutical, Inc.: Series B $22.5M

BioAmber, Inc.: Series C $30M

LanzaTech, Ltd.: $55.8M Series C

Pharma needs to rethink supply chains in an era of patent expiry and global outsourcing

European CMO market will double in just 6 years, says Frost & Sullivan

Social network sites is key to trial recruitment success, says expert

Social network sites key to trial recruitment success, says expert

An experienced CMO is key to successful biologics development says Cobra Biologics

Pharma News - Business Wire
Galectin Therapeutics Inc. Announces Exercise of Over-Allotment Option

Seattle Genetics Announces Pivotal ADCETRIS (Brentuximab Vedotin) Hodgkin Lymphoma Study Published in Journal of Clinical Oncology

Verastem Congratulates Co-founder Robert Weinberg and Announces the Presentation of Data at the 2012 AACR Annual Meeting

Research and Markets: Osteopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Pharma and Biotech Licensing Deals Cost up to $8 Million to Complete, Finds Cutting Edge Information

Pharma News - PharmiWeb
EHNAC Appoints Two New Commissioners

Relaxation Beverage Growth Featured on CNBC's 'Hot Start Ups' Segment; BeBevCo's Koma Unwind Growing Fast!

The Value of Real-Time Locating Systems to All Businesses

Have You Heard the One About Comedians and Psychologists

To Drive Infection, a Hijacking Virus Mimics a Cell's Signaling System

Pharma News - PR Newswire
Sunpeaks Ventures Announces Clotamin to be Sold at Bravo Supermarkets in South Florida

Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia

Tengion Announces Significant Advances in Neo-Urinary Conduit and Neo-Kidney Augment Programs

Crestor Delivers Latest LDL-C Targets in High-Risk Patients at Lower Doses than Other Statins

Patients Who Know Their Gene Test Results are More Likely to Regularly Take and Remain on Statins, Study at ACC Shows

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

Ascent Scientific licenses novel clathrin inhibitors from Freie Universität Berlin, University of Newcastle and Children's Medical Research Institute

PRWeb - Biotechnology
Stem Cell Study Aids Quest for ALS Therapies

Antibody Agreements Reviewed in New CurrentPartnering Study Now...

Mega Sale on Philips Respironics EverGo Portable Oxygen Concentrator...

Chugai Pharmaceutical Extends Multi-Year Licensing of Genedata...

Cambridge Healthtech Associates Expands Consulting Services into...

PRWeb - Pharmaceuticals
Rottenstein Law Group Heeds Court Order Setting First Dates in Wright...

Granard Pharmaceutical Sales and Marketing Has Been Retained by...

HealthyPlace.com Seeks Stories About Mental Illness Stigma Experiences

Health First Rx Celebrates Grand Opening

Affordable Care Partners with Viva Learning For New Dental CE Website

Scientific American
Controversy Surrounds Russia's Claim that Cosmic Rays Caused Mars Mission Failure

Evidence for Flowing Water on Mars Grows Stronger

Health Care Reform on Trial: What's at Stake in the Upcoming Supreme Court Arguments

The Ballooning Brain: Defective Genes May Explain Uncontrolled Brain Growth in Autism

Big Kill, Not Big Chill, Finished Off Giant Kangaroos

Sports - ESPN Basketball
Murray State, Prohm agree to extend contract

Duke's Rivers enters NBA draft, will hire agent

Drexel to sign coach Flint to contract extension

Source: Beavers G Cunningham to 'test' draft

KSU's Martin to consider South Carolina offer

Sports News - ESPN
Penn State to hold 3-way competition for QB

Alabama grants Saban raise, 2-year extension

Four QBs vying for starting job at Notre Dame

Report: Sandusky called 'likely pedophile' in '98

Report: L.A. police investigating Chadima claim

Xconomy Life Sciences
PATH Names Former Tech Exec Steve Davis as New CEO

San Diego Tech Roundup: Flud, Verve, and a 'swiss Cheese Job Market

Aveo's Ha-Ngoc to Interview Third Rock's Mark Levin at April 4 Forum

Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks

Glaxo and J&J's Shrewd Move Will Help the Biotech Ecosystem

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)